Marshall Wace’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Sell
158,900
-259,729
-62% -$4.59M ﹤0.01% 1641
2025
Q4
$7.83M Buy
418,629
+60,978
+17% +$1.01M 0.01% 964
2025
Q3
$5.22M Buy
357,651
+256,873
+255% +$3.25M 0.01% 1169
2025
Q2
$1.11M Buy
100,778
+85,867
+576% +$835K ﹤0.01% 1800
2025
Q1
$133K Sell
14,911
-51,156
-77% -$476K ﹤0.01% 2464
2024
Q4
$622K Sell
66,067
-83,993
-56% -$764K ﹤0.01% 1954
2024
Q3
$1.21M Sell
150,060
-147,439
-50% -$1.28M ﹤0.01% 1572
2024
Q2
$2.52M Buy
297,499
+135,426
+84% +$1.22M ﹤0.01% 1263
2024
Q1
$1.45M Buy
+162,073
New +$1.5M ﹤0.01% 1503
2023
Q4
Sell
-20,400
Closed -$176K 2643
2023
Q3
$176K Sell
20,400
-39,412
-66% -$380K ﹤0.01% 1996
2023
Q2
$619K Buy
+59,812
New +$660K ﹤0.01% 1906
2020
Q3
Sell
-14,990
Closed -$315K 1920
2020
Q2
$315K Buy
+14,990
New +$385K ﹤0.01% 1314
2019
Q2
Sell
-4,080
Closed -$92K 1829
2019
Q1
$92K Hold
4,080
﹤0.01% 1447
2018
Q4
$104K Buy
+4,080
New +$110K ﹤0.01% 1361
2017
Q1
Sell
-408,880
Closed -$13M 717
2016
Q4
$13M Buy
408,880
+329,812
+417% +$10.2M 0.09% 267
2016
Q3
$2.87M Buy
79,068
+55,362
+234% +$1.54M 0.02% 518
2016
Q2
$538K Buy
+23,706
New +$512K ﹤0.01% 814

Other funds holding TBPH